Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results

NEXT STORY
Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil
PREV STORY
Global Cell Analysis Instruments Market (2020 to 2025) – Growth, Trends, and Forecasts
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Versartis Reports Confirmatory Top-Line Two-Year Data from Ongoing Extension Study of Somavaratan in GHD Children

Safe and well tolerated over two yearsHeight velocity (HV) in second year comparable to ...

author_avatar
NASDAQ Market News

TESARO Announces Closing of $155 Million Private Placement

WALTHAM, Mass., March 18, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News

BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China

BEIJING, China, and CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

author_avatar
NASDAQ Market News